Abstract
Blood outgrowth endothelial cells (BOECs) are important tools when investigating diagnostic and therapeutic approaches for vascular disease. In this protocol, mononuclear cells are isolated from peripheral blood and plated on type I collagen at ∼135,000 cells per cm2 in endothelial cell differentiation medium. On average, 0.34 colonies of endothelial cells per milliliter of blood can be obtained. Colonies of endothelial cells become visible after 14–28 d. Upon confluence, these rapidly expanding colonies can be passaged and have been shown to propagate up to 1018-fold. Isolated BOECs are phenotypically similar to vascular endothelial cells, as revealed by their cobblestone morphology, the presence of endothelial cell–specific Weibel-Palade bodies and the expression of endothelial cell markers such as VE-cadherin. The protocol presented here also provides a particularly useful tool for the ex vivo assessment of endothelial cell function from patients with different vascular abnormalities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aird, W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100, 158–173 (2007).
Aird, W.C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100, 174–190 (2007).
Pober, J.S. & Tellides, G. Participation of blood vessel cells in human adaptive immune responses. Trends Immunol. 33, 49–57 (2012).
Navarro, S. et al. The endothelial cell protein C receptor: its role in thrombosis. Thromb. Res. 128, 410–416 (2011).
Hasstedt, S.J. et al. Cell adhesion molecule 1: a novel risk factor for venous thrombosis. Blood 114, 3084–3091 (2009).
de Groot, P.G. et al. von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets. Proc. Natl. Acad. Sci. USA 86, 3793–3797 (1989).
Federici, A.B. et al. Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells. Br. J. Haematol. 83, 88–93 (1993).
Ewenstein, B.M., Inbal, A., Pober, J.S. & Handin, R.I. Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease. Blood 75, 1466–1472 (1990).
Lin, Y., Weisdorf, D.J., Solovey, A. & Hebbel, R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105, 71–77 (2000).
Medina, R.J. et al. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med. Genomics 3, 18 (2010).
Gulati, R. et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108, 1520–1526 (2003).
Hirschi, K.K., Ingram, D.A. & Yoder, M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 1584–1595 (2008).
Jiang, A., Pan, W., Milbauer, L.C., Shyr, Y. & Hebbel, R.P. A practical question based on cross-platform microarray data normalization: are BOEC more like large vessel or microvascular endothelial cells or neither of them? J. Bioinform. Comput. Biol. 5, 875–893 (2007).
Pan, W., Shen, X., Jiang, A. & Hebbel, R.P. Semi-supervised learning via penalized mixture model with application to microarray sample classification. Bioinformatics 22, 2388–2395 (2006).
Rondaij, M.G., Bierings, R., Kragt, A., van Mourik, J.A. & Voorberg, J. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26, 1002–1007 (2006).
van den Biggelaar, M. et al. Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells. Haematologica 94, 670–678 (2009).
van den Biggelaar, M., Bouwens, E.A., Voorberg, J. & Mertens, K. Storage of factor VIII variants with impaired von Willebrand factor binding in Weibel-Palade bodies in endothelial cells. PLoS. ONE 6, e24163 (2011).
Valentijn, K.M., Sadler, J.E., Valentijn, J.A., Voorberg, J. & Eikenboom, J. Functional architecture of Weibel-Palade bodies. Blood 117, 5033–5043 (2011).
Bouwens, E.A. et al. Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies. Blood 118, 5947–5956 (2011).
Fernandez, L.A. et al. Blood outgrowth endothelial cells from hereditary haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc. Res. 68, 235–248 (2005).
Chang Milbauer, L. et al. Genetic endothelial systems biology of sickle stroke risk. Blood 111, 3872–3879 (2008).
Wei, P. et al. Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. BMC Med. 9, 2 (2011).
Milbauer, L.C. et al. Blood outgrowth endothelial cell migration and trapping in vivo: a window into gene therapy. Transl. Res. 153, 179–189 (2009).
Matsui, H. et al. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells 25, 2660–2669 (2007).
De Meyer, S.F. et al. Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor. Blood 107, 4728–4736 (2006).
Dudek, A.Z. et al. Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. Br. J. Cancer 97, 513–522 (2007).
Bodempudi, V. et al. Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors. Cancer Gene Ther. 17, 855–863 (2010).
Critser, P.J. & Yoder, M.C. Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Curr. Opin. Organ Transplant. 15, 68–72 (2010).
Au, P. et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111, 1302–1305 (2008).
Medina, R.J., O'Neill, C.L., Humphreys, M.W., Gardiner, T.A. & Stitt, A.W. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest. Ophthalmo. Vis. Sci. 51, 5906–5913 (2010).
Schwarz, T.M. et al. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy. Arterioscler. Thromb. Vasc. Biol. 32, e13–e21 (2012).
Lin, Y. et al. Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 99, 457–462 (2002).
Moubarik, C. et al. Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke. Stem Cell Rev. 7, 208–220 (2011).
Reinisch, A. et al. Humanized large-scale expanded endothelial colony-forming cells functions in vitro and in vivo. Blood 113, 6716–6725 (2009).
Somani, A. et al. The establishment of murine blood outgrowth endothelial cells and observations relevant to gene therapy. Transl. Res. 1, 30–39 (2007).
van Agtmaal, E. et al. The shear stress-induced transcription factor KLF2 affects dynamics and angiopoietin-2 content of Weibel-Palade bodies. PLoS ONE 7, e38399 (2012).
Acknowledgements
J.M.-R. and M.H. are supported by a grant from Center for Translational Molecular Medicine, grant no. INCOAG-01C-201-04. R.P.H. is supported by US National Institutes of Health grants HL62931 and HL55552.
Author information
Authors and Affiliations
Contributions
J.M.-R., M.H. and J.V. developed the current protocol that is based on the original protocol described by Lin and co-workers. J.M.-R., M.H., M.v.d.B., R.P.H. and J.V. wrote the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Martin-Ramirez, J., Hofman, M., van den Biggelaar, M. et al. Establishment of outgrowth endothelial cells from peripheral blood. Nat Protoc 7, 1709–1715 (2012). https://doi.org/10.1038/nprot.2012.093
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2012.093
This article is cited by
-
Establishment of the deuterium oxide dilution method as a new possibility for determining the transendothelial water permeability
Pflügers Archiv - European Journal of Physiology (2024)
-
Multi-omics delineation of cytokine-induced endothelial inflammatory states
Communications Biology (2023)
-
Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease
Cell and Tissue Research (2022)
-
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix
BMC Cancer (2021)
-
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Nature Genetics (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.